Today's Daily Dose brings you news about stock offerings of AnaptysBio and Opiant Pharma; Entasis Therapeutics' IPO; Cidara's lead antifungal product candidate, Rezafungin, securing Qualified Infectious Disease Product and Fast Track designations, and Tandem Diabetes' revised sales outlook for 2018.
from RTT - Biotech https://ift.tt/2DujnOz
via IFTTT
No comments:
Post a Comment